BDKRB2 and neoplasm: It is well known that there are tumor volume and location dependent differences in the transvascular flow rate across BBTB at baseline[31,32] within the same brain, however the significance of these differences has not yet been established in context of the systemic actions of bradykinin B2 receptor agonists of a wide range of metabolic stabilities[33].